PlainPill

MK-2866 vs TB-500 for recovery

Short answer: For recovery, users rate them about the same: 96% report improvement with MK-2866 (78 reports) and 96% with TB-500 (297 reports).

MK-2866 has 0 meta-analyses and 0 randomized trials on PubMed; TB-500 has 0 and 3.

Based on 789 reports about MK-2866 and 874 about TB-500. Not medical advice.

MK-2866
SARM
TB-500
Peptide
Users say it helped37%helped489 reports · high confidence65%helped402 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchDResearch: NoneCResearch: Limited
Meta-analyses / RCTs0 / 00 / 3
Mainly used for
Recovery
% reporting improvement
96% (78)96% (297)
Performance
% reporting improvement
87% (252)96% (26)
Pain & inflammation
% reporting improvement
71% (31)86% (199)
Weight loss
% reporting improvement
88% (100)100% (8)
Hormones
% reporting improvement
3% (100)—
Common side effectssuppression, fatigue, insomnia, headacheanxiety, fatigue, dizziness, allergic reaction
Typical dose reportedNot listedNot listed
MK-2866
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full MK-2866 profile →
TB-500
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Full TB-500 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate